Anthropic's IPO poses this big risk to an already shaky stock market
By Joseph Adinolfi
Investors are worried that a flood of equity issuance could overwhelm demand
Anthropic's long-awaited IPO has finally arrived.
The U.S. stock market was already making investors nervous, as the artificial-intelligence trade has sputtered recently.
The big fear on Thursday is that Anthropic's (ANT) record initial public offering could push major indexes over the edge - and the S&P 500 SPX possibly into correction territory, defined as a drop of 10% or more from a recent high - as investors make room in their portfolios for the newly issued shares.
The supply of new shares has surged this year, largely due to megaofferings from SpaceX (SPCX) and now Anthropic, whose shares were due to start trading on Thursday after pricing at a fully diluted valuation of $1.5 trillion.
Owen Lamont, a portfolio manager at quantitative investment shop Acadian Asset Management, warned in a recent commentary piece that over the past 12 months, net new equity issuance - which factors in buybacks, IPOs, secondary offerings and private placements - has already surged to $2.4 trillion. Anthropic is raising more than $80 billion, in addition to $26 billion in private placements with Advanced Micro Devices (AMD) and other major tech firms.
One large IPO, SpaceX, and a handful of smaller offerings have helped to juice this trend. Meanwhile, megacap companies like Meta Platforms (META), Alphabet (GOOGL) (GOOG) and Tesla (TSLA) have ramped up issuance of new stock to help finance their business ambitions.
While net issuance is still below the peaks seen during the dot-com bubble and the COVID-19 meme-stock craze in 2021, it is clear that the long period when companies were buying back more shares than they were issuing has ended, Lamont said. Although the sample size is small, previous periods of heavy issuance have presaged long stretches of stock-market weakness.
"Firms are the smart money: They repurchase shares when their stock is undervalued and issue shares when it's overvalued. Buy low, sell high. Everyone tries to do it; firms actually succeed on average," Lamont wrote.
To be sure, not everybody is quite so concerned. A team of equity analysts at J.P. Morgan said in a recent report that fears about the flood of issuance weighing on the market this year have been overblown. While the dollar figure of expected issuance remains large, the number of IPOs is on track to be lower than last year, and well below the 2021 peak of more than 1,200.
The risk that lockup expirations for insiders and early investors could hurt the market - a widely shared concern ahead of the SpaceX IPO - also apparently hasn't materialized, and the J.P. Morgan team said there's a reason for that.
While lockup expirations mechanically increase a company's free float, they don't automatically translate to more supply on the market. If anything, a larger free float will drive more buying by passive investors by eventually driving a bigger weighting in indexes like the Nasdaq-100 NDX or S&P 500, the J.P. Morgan team said.
They also pointed out that, relative to the market valuation of all stocks trading around the world, this year's spate of issuance looked relatively modest.
Biggest ever
Anthropic edged out SpaceX for the largest-ever IPO measured by gross proceeds - the amount of money raised by the company and its shareholders.
Whatever impact the listing has on the broader market remains to be seen. Major indexes rose at Thursday's open, in anticipation of strong demand for Anthropic's stock when it starts trading, but the gains quickly evaporated as the debut neared. Weeks ago, Anthropic's offering documents helped to revive investors' confidence that being a frontier AI lab will ultimately prove to be not just a sustainable business, but a lucrative one.
Still, the broader stock market remains in rough shape. The S&P 500 recently broke below its 200-day moving average, seen as a sign that the long-term trend for the index might be shifting lower. It was on track to close at a five-month low as of Thursday morning.
Panmure Liberum strategist Joachim Klement said this week that he is selling all of his stocks, after having virtually all of his retirement portfolio in equities for years.
Investors are increasingly waking up to the reality that, as long as semiconductor stocks and other tech names struggle, the S&P 500 will struggle to move meaningfully higher - even if strength in other parts of the market has helped to buttress the S&P 500 against a deeper decline.
The success of Anthropic's IPO could also have implications for Big Tech earnings. Both Amazon.com (AMZN) and Alphabet own sizable stakes in Anthropic. Revaluing those stakes higher contributed significantly to their net income growth in 2026.
"Big Tech earnings are increasingly exposed to Anthropic's valuation. Every $10 move in Anthropic's share price could change Amazon's and Alphabet's combined pretax earnings by roughly $37 billion," wrote David Rosenberg, founder and president of Rosenberg Research & Associates, in commentary shared with MarketWatch.
-Joseph Adinolfi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-19-26 1149ET
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

7 Undervalued Stocks That Crushed Earnings

The 10 Best Dividend Stocks

This Newly Undervalued Stock Has Plenty of Growth Ahead

